Tervisetehnoloogiate Arenduskeskus AS is a biotechnology company focused on research and product development in personal medicine, drug development and both human and veterinary reproductive medicine. Company collaborates closely with leading Estonian scientists, universities and biotechnology companies as well as scientific, medical and R&D institutions from Europe, Asia and America.
Overview of project
-
The main goal of this project is to enhance the value of current portfolio of products, specifically NIPTIFY (non-invasive prenatal test, NIPT) for foetal health screening, by enhancing the data received from a single blood sample.
-
The long-term goal is to provide a personalized medicine solution for prenatal care that is cost-effective and easily scalable. The development of innovative products, as NIPTIFY+, including services and processes supported by ICT, will lead to the more personalized preventive approach in primary care.
-
NIPTIFY+ is a non-invasive test, that, in addition to the risks of foetal chromosome abnormalities, allows to determine the risk of the serious diseases of a mother during pregnancy
